Thursday, July 13, 2017 10:42:41 AM
Recent DARE News
- Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites • GlobeNewswire Inc. • 11/13/2024 01:00:00 PM
- Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024 • GlobeNewswire Inc. • 11/07/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 12:01:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 04:31:39 PM
- Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health • GlobeNewswire Inc. • 10/23/2024 04:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 09:00:35 PM
- Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC • GlobeNewswire Inc. • 10/21/2024 12:05:00 PM
- Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% • GlobeNewswire Inc. • 08/26/2024 12:00:00 PM
- Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6% • GlobeNewswire Inc. • 08/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:05:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:01:31 PM
- Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 08/12/2024 08:01:00 PM
- Daré Bioscience to Host Second Quarter 2024 Financial Results and Company Update Conference Call and Webcast on August 12, 2024 • GlobeNewswire Inc. • 08/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 12:05:26 PM
- Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule • GlobeNewswire Inc. • 07/19/2024 12:00:00 PM
- Daré Bioscience Announces Reverse Stock Split • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder • GlobeNewswire Inc. • 06/24/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:15:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:15:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:15:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:05:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 12:05:24 PM
- Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/13/2024 04:15:35 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM